CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced Ken Anderson, M.D., Nathanael Gray, Ph. D., Christopher Kirk, Ph. D. and Eric Fischer, Ph.
CAMBRIDGE, Mass.– C4 Therapeutics (C4T) today announced that Andrea Armstrong has been promoted to Chief Administrative Officer. She joined C4T as
CAMBRIDGE, Mass. — C4 Therapeutics (C4T) today announced that it has been named by FierceBiotech as one of 2016’s Fierce 15
CAMBRIDGE, Mass. — C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been promoted to President and Chief Scientific
Highlights Leadership in Biology, Chemistry, Discovery Sciences, Translational Sciences and Alliance Management CAMBRIDGE, Mass. — C4 Therapeutics (C4T) today announced
CAMBRIDGE, Mass.– C4 Therapeutics today announced the appointment of Andrew Phillips, Ph.D. as Chief Scientific Officer. Dr. Phillips joins from
Finding a way to trick the ubiquitin proteasome system, C4 Therapeutics, a spin-out from Harvard’s Dana-Farber Cancer Institute, has developed
Read the full release on the Xconomy.com website. News
Read the full release on the Forbes.com website. News
